Release of creatine phosphokinase from muscle. II. Effect of multiple doses of polymyxin B or compound 48-80 on increases in plasma enzyme levels.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002746:Chlorpromazine / Q000494:pharmacology; D003080:Cold Temperature; D003402:Creatine Kinase / Q000097:blood / Q000378:metabolism*; D004361:Drug Tolerance; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000201:enzymology*; D010622:Phencyclidine / Q000494:pharmacology; D011113:Polymyxins / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013312:Stress, Physiological / Q000201:enzymology; D013997:Time Factors; D003189:p-Methoxy-N-methylphenethylamine / Q000008:administration & dosage / Q000494:pharmacology*
D011113:Polymyxins; D003189:p-Methoxy-N-methylphenethylamine; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D010622:Phencyclidine; D002746:Chlorpromazine